Related Experiment Videos
[Cytoprotection of gastric mucosa: myth or reality?]
Gastroenterologie Clinique Et Biologique
|June 1, 1980
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Migraine prevalence in inflammatory bowel disease patients: A tertiary-care centre cross-sectional study.
European journal of pain (London, England)·2017
Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
Alimentary pharmacology & therapeutics·2016
[Natural history of portal cavernoma without liver disease. A single centre retrospective study of 32 cases].
La Revue de medecine interne·2015
Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease.
Journal of Crohn's & colitis·2015
[Treatment of chronic hepatitis B: adherence and safety].
Gastroenterologie clinique et biologique·2010
[Long-term therapy for chronic hepatitis B in HIV co-infected patients].
Gastroenterologie clinique et biologique·2010
[Analogs combination therapy in chronic hepatitis B: when and how?].
Gastroenterologie clinique et biologique·2010
[HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
Gastroenterologie clinique et biologique·2010
[HBsAg quantification: virological significance].
Gastroenterologie clinique et biologique·2010
[Influence of treatment on long-term evolution of chronic hepatitis B].
Gastroenterologie clinique et biologique·2010
An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.
Neurological research·2026
Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026
Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.
Endocrine-related cancer·2026
Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.
Cancer cytopathology·2026
PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.
Pakistan journal of pharmaceutical sciences·2026